CDK11 regulates pre-mRNA splicing by phosphorylation of SF3B1

Milan Hluchý,Pavla Gajdušková,Igor Ruiz de los Mozos,Michal Rájecký,Michael Kluge,Benedict-Tilman Berger,Zuzana Slabá,David Potěšil,Elena Weiß,Jernej Ule,Zbyněk Zdráhal,Stefan Knapp,Kamil Paruch,Caroline C. Friedel,Dalibor Blazek
DOI: https://doi.org/10.1038/s41586-022-05204-z
IF: 64.8
2022-09-15
Nature
Abstract:RNA splicing, the process of intron removal from pre-mRNA, is essential for the regulation of gene expression. It is controlled by the spliceosome, a megadalton RNA–protein complex that assembles de novo on each pre-mRNA intron through an ordered assembly of intermediate complexes 1,2 . Spliceosome activation is a major control step that requires substantial protein and RNA rearrangements leading to a catalytically active complex 1,2,3,4,5 . Splicing factor 3B subunit 1 (SF3B1) protein—a subunit of the U2 small nuclear ribonucleoprotein 6 —is phosphorylated during spliceosome activation 7,8,9,10 , but the kinase that is responsible has not been identified. Here we show that cyclin-dependent kinase 11 (CDK11) associates with SF3B1 and phosphorylates threonine residues at its N terminus during spliceosome activation. The phosphorylation is important for the association between SF3B1 and U5 and U6 snRNAs in the activated spliceosome, termed the B act complex, and the phosphorylation can be blocked by OTS964, a potent and selective inhibitor of CDK11. Inhibition of CDK11 prevents spliceosomal transition from the precatalytic complex B to the activated complex B act and leads to widespread intron retention and accumulation of non-functional spliceosomes on pre-mRNAs and chromatin. We demonstrate a central role of CDK11 in spliceosome assembly and splicing regulation and characterize OTS964 as a highly selective CDK11 inhibitor that suppresses spliceosome activation and splicing.
multidisciplinary sciences
What problem does this paper attempt to address?